Security file · CUSIP 10806X102
BBIO
BRIDGEBIO PHARMA INC · US listing · held by 1 tracked manager in Q3 2026.
Tracked holders · Q3 2026
1
-1 vs Q2 2026
Aggregate reported value
$297K
sum of holders' reported positions
New holders this quarter
0
1 added · 0 trimmed
Holder return since filing
-0.8%
weighted by each holder's position share · since filing
Ownership · Q3 2026
| Manager | Weight | Shares | Δ shares | Entry | Return | Value | Activity | |
|---|---|---|---|---|---|---|---|---|
| 1 | Polen Capital Managementfiled 13 Nov ET | 0.00% | 4,510 | +12.7% | $78 | -0.8% | $297K | Added |
Holder count
Aggregate reported value
Quarterly aggregation
| Quarter | Holders | Δ holders | Aggregate value | Total shares |
|---|---|---|---|---|
| Q3 2026 | 1 | -1 | $297K | 4,510 |
| Q2 2026 | 2 | +1 | $741M | 9.95M |
| Q1 2026 | 1 | +0 | $879M | 11.84M |
| Q4 2025 | 1 | -1 | $1.10B | 14.39M |
| Q3 2025 | 2 | +1 | $832M | 16.01M |
| Q2 2025 | 1 | +0 | $801M | 18.56M |
| Q1 2025 | 1 | +0 | $762M | 22.06M |
| Q4 2024 | 1 | +0 | $689M | 25.12M |
| Q3 2024 | 1 | — | $640M | 25.12M |